217 results about "Hypertensive disease" patented technology

The invention provides a health-care tea drink with a blood pressure lowering effect. The health-care tea drink comprises black tea, burdock, hawthorn, chrysanthemum, lotus leaf, seed of feather cockscomb, dandelion, root of kudzu vine, dogbane leaf, ovientvine, fructus liquidambaris, poria cocos, plantain seed, coix seed, morinda root, uncaria, astragalus, root of bidentate achyranthes, corydalis tuber, rhodiola rosea, cocklebur fruit, liquoric root, bamboo shavings and sea tangle. The health-care tea drink can be drunk in daily life for preventing and treating hypertension; stabilization ofblood pressure of a patient with the hypertension can be promoted and the incidence of the hypertension can be prevented by drinking the health-care tea drink provided by the invention for long time;and since the in-vivo blood pressure is reduced in daily tea drinking habit, the repeated illness and accidents caused by interrupted administration of medicines can also be prevented.

Disclosed is a hypertension descending device capable of curing a hypertension disease by stimulating a patient's Acupuncture point Renying (or referred to as “carotid sinus”) by repeated cold pressure vibration. The hypertension descending device is designed to allow common users to use it easily, and provides a good hypertension descent effect by stimulating the patient's carotid sinus(Acupuncture point Renying) portion while maintaining a uniform cooling temperature of the contact tip, which is in contact with the patient's carotid sinus(Acupuncture point Renying) portion.

The invention provides methods for (a) prolonging time to hospitalization for heart failure; (b) prolonging time to first hospitalization for heart failure; (c) reducing the total number of days a patient with heart failure spends in the hospital for heart failure for a single hospital stay (i.e., reducing the duration of a single hospital stay for a patient with heart failure); (d) reducing the total number of days a patient spends in the hospital for heart failure for multiple hospital stays (i.e., two or more hospital stays); (e) reducing the number of hospital admissions for heart failure; (f) reducing mortality and reducing hospitalizations for heart failure (e.g., the total number of days in the hospital and / or the number of hospital visits); (g) increasing the left ventricular ejection fraction in a heart failure patient; (h) treating a sexual dysfunction (e.g., erectile dysfunction and female sexual dysfunction) (j) treating a headache in a heart failure patient by administering a non-steroidal antiinflammatory compound (i.e., NSAIDs); (k) treating a heart failure patient who has a history of hypertension (but who is not currently diagnosed with hypertension); (l) improving the quality of life in a heart failure patient based on the Minnesota Living with heart failure questionnaire; (m) decreasing the levels of B-type natriuretic peptide; (n) treating hypertension in a heart failure patient; (o) lowering blood pressure in a heart failure patient; (p) treating labile hypertension; (q) treating idiopathic hypertension; (r) increasing patient compliance with medication dosing in a heart failure patient; (s) treating hypertension in a patient with a dilated heart; (t) treating ischemic disease and / or coronary artery disease; and (u) reducing cardiomegaly in a patient in need thereof comprising administering to the patient a therapeutically effective amount of (i) a hydralazine compound or pharmaceutically acceptable salt thereof, (ii) isosorbide dinitrate and / or isosorbide mononitrate, and (iii) optionally at least one compound selected from the group consisting of angiotensin converting enzyme inhibitors, β-adrenergic antagonists, angiotensin II antagonists, aldosterone antagonists, cardiac glucosides (digitalis), and diuretic compounds.

Disclosed is a Chinese medicinal composition for treating hyperlipemia, hypertension and coronary disease, which comprises the following constituents (by weight portions): haw 6-9 parts, root of red rooted saliva 3-4 parts, leech 2.5-3.5 parts, abalone shell 4-6 parts, white peony root 4-6 parts, chrysanthemum flower 3-5 parts, selfheal 3-5 parts, mulberry leaf 2.5-3.5 parts, cassia seed 3-5 parts, safflower 2-3 parts, hooked uncaria 2.5-3.5 parts, and plantain seed 0.5-1.5 parts, and green tea 2-4 parts. The composition can be made into pills or capsules.

The invention discloses a flour compound suitable for hypertensive disease patients. The flour compound is made of semen Raphani, medlar, burdock roots, ginkgo leaves, radix puerariae, herba epimedii, chrysanthemum, rhynchophylla, eucommia, tabasheer, hawthorn, ginseng, mulberry leaves, Chinese yam, sweet potatoes, pea flour and whole wheat flour. The invention also discloses a preparation method of the flour compound. By eating the flour compound provided in the invention, blood pressure rise can be effectively controlled, and the adverse effects caused by drug therapy can be reduced.